The peptide neurotensin (NT) is known to exert a potent excitatory effect on the dopaminergic system by inhibiting D2 dopamine (DA) receptor (D2R) function. This regulation is dependent on activation of PKC, a well known effector of the type 1 NT receptor (NTR1). Because PKC phosphorylation of the D2R has recently been shown to induce its internalization, we hypothesized that NT acts to reduce D2R function through heterologous desensitization of the D2R. In the present study, we first used HEK-293 cells to demonstrate that NT induces PKC-dependent D2R internalization. Furthermore, internalization displayed faster kinetics in cells expressing the D2R short isoform, known to act as an autoreceptor in DA neurons, than in cells expressing the long isoform, known to act as a postsynaptic D2R. In patch clamp experiments on cultured DA neurons, overexpression of a mutant D2S lacking three key PKC phosphorylation sites abrogated the ability of NT to reduce D2R-mediated cell firing inhibition. Short interfering RNA-mediated inhibition of -arrestin1 and dynamin2, proteins important for receptor desensitization, reduced agonist-induced desensitization of D2R function, but only the inhibition of -arrestin1 reduced the effect of NT on D2R function. Taken together, our data suggest that NT acutely regulates D2 autoreceptor function and DA neuron excitability through PKC-mediated phosphorylation of the D2R, leading to heterologous receptor desensitization.Since its discovery in the 1970s, NT 2 has been well established as a potent modulator of the DA system (1, 2). A vast majority of DA neurons in the substantia nigra and the ventral tegmental area express NTR1, the high affinity NT receptor (3, 4). Activation of these G␣ q -coupled receptors has been shown to increase DA neuron excitability via distinct mechanisms, one of which consists in a reduction of presynaptic D2 autoreceptor function (5-8). Activation of these D2Rs by DA normally causes cell hyperpolarization, which leads to a decrease in both spontaneous firing and DA release (9 -13). D2R regulation is an important area of interest for modern neuropharmacology because all clinically effective antipsychotic drugs (APDs) act at least in part as D2R antagonists. Moreover, because a growing amount of data from both human and animal studies provides evidence for the implication of NT in the pathophysiology of schizophrenia and in the action of APDs (14 -22), a better understanding of the mechanism mediating the NTR1-D2R interaction seems necessary.The major second messenger cascade triggered by NTR1 signaling involves activation of phospholipase C and the subsequent increase in intracellular calcium concentration, inositoltriphosphate production, and PKC activity, all of which have been linked to physiological effects of NT (7,(23)(24)(25)(26). We have previously demonstrated that the regulation of D2R function by NT in cultured DA neurons requires PKC activity (27). Interestingly, it was also shown that the D2R can be directly phosphorylated by PKC, leading to agonist-i...